{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:24:48Z","timestamp":1792164288203,"version":"4.4.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Society of Hypertension"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jash.2012.11.003","type":"journal-article","created":{"date-parts":[[2012,12,22]],"date-time":"2012-12-22T08:15:37Z","timestamp":1356164137000},"page":"61-67","source":"Crossref","is-referenced-by-count":16,"title":["Cardiovascular effects of pharmacologic therapies for smoking cessation"],"prefix":"10.1016","volume":"7","author":[{"given":"Diana M.","family":"Sobieraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William B.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jash.2012.11.003_bib1","unstructured":"Smoking and tobacco use. Centers for Disease Control and Prevention. Available at: http:\/\/www.cdc.gov\/tobacco\/data_statistics\/fact_sheets\/health_effects\/effects_cig_smoking\/index.htm. Accessed August 24,\u00a02012."},{"key":"10.1016\/j.jash.2012.11.003_bib2","unstructured":"Statistical brief #7. Smoking status of adults\u2014United States, 2000. Agency for Healthcare Research and Quality. Available at: http:\/\/meps.ahrq.gov\/mepsweb\/data_files\/publications\/st7\/stat07.shtml. Accessed August 24,\u00a02012."},{"key":"10.1016\/j.jash.2012.11.003_bib3","series-title":"Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline","author":"Fiore","year":"2008"},{"key":"10.1016\/j.jash.2012.11.003_bib4","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archinte.1994.00420090063007","article-title":"Nicotine replacement therapy for patients with coronary artery disease","volume":"154","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jash.2012.11.003_bib5","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJM199612123352402","article-title":"The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease","volume":"335","author":"Joesph","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jash.2012.11.003_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/CIRCULATIONAHA.109.869008","article-title":"Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial","volume":"121","author":"Rigotti","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2012.11.003_bib7","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1001\/jama.1986.03370080040015","article-title":"Atrial fibrillation while chewing nicotine gum","volume":"255","author":"Rigotti","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2012.11.003_bib8","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/eurheartj\/14.12.1709","volume":"14","author":"Dacosta","year":"1993","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jash.2012.11.003_bib9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1177\/106002809402800320","article-title":"Stroke following application of a nicotine patch","volume":"28","author":"Pierce","year":"1994","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jash.2012.11.003_bib10","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0735-1097(97)00079-X","article-title":"Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy","volume":"29","author":"Benowitz","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jash.2012.11.003_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0033-0620(03)00087-2","article-title":"Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment","volume":"46","author":"Benowitz","year":"2003","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jash.2012.11.003_bib12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/pcad.2003.YPCAD14","article-title":"Safety issues in pharmacotherapy for smoking in patients with cardiovascular disease","volume":"45","author":"Joseph","year":"2003","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jash.2012.11.003_bib13","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.jacc.2003.12.047","article-title":"The pathophysiology of cigarette smoking and cardiovascular disease. An update","volume":"43","author":"Ambrose","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jash.2012.11.003_bib14","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJM198811173192005","article-title":"Pharmacologic aspects of cigarette smoking and nicotine addiction","volume":"319","author":"Benowitz","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jash.2012.11.003_bib15","first-page":"411","article-title":"Acute effects of low dose nicotine gum on platelet function in non-smoking hypertensive and normotensive men","volume":"41","author":"Mundal","year":"1995","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jash.2012.11.003_bib16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00823596","article-title":"Effects of transdermal nicotine patches on ambulatory ECK monitoring findings: A double-blind study in healthy smokers","volume":"10","author":"Khoury","year":"1996","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jash.2012.11.003_bib17","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1055\/s-0038-1657692","article-title":"The influence of smoking and of oral and transdermal nicotine on blood pressure, and haematology and coagulation indices","volume":"78","author":"Blann","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jash.2012.11.003_bib18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0735-1097(97)00128-9","article-title":"Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia","volume":"30","author":"Mahmarian","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jash.2012.11.003_bib19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0009-9236(98)90026-1","article-title":"Dose-related cardiovascular and endocrine effects of transdermal nicotine","volume":"64","author":"Zevin","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jash.2012.11.003_bib20","first-page":"435","article-title":"Pharmacokinetics and pharmacodynamic effects of nicotine nasal spray devices on cardiovascular and pulmonary function","volume":"48","author":"Fishbein","year":"2000","journal-title":"J Investig Med"},{"key":"10.1016\/j.jash.2012.11.003_bib21","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0895-7061(01)01301-2","article-title":"Cardiovascular effects of transdermal nicotine in mildly hypertensive smokers","volume":"14","author":"Tanus-Santos","year":"2001","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jash.2012.11.003_bib22","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1161\/01.CIR.80.5.1309","article-title":"Inverse relationship between serum cotinine concentration and blood pressure in cigarette smokers","volume":"80","author":"Benowitz","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2012.11.003_bib23","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1161\/01.HYP.0000018825.76673.EA","article-title":"Cardiovascular effects of nasal and transdermal nicotine and cigarette smoking","volume":"39","author":"Benowitz","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2012.11.003_bib24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.1365-2796.2002.01014.x","article-title":"Effects of cigarette smoking or nicotine replacement on cardiovascular risk factors and parameters of haemorheology","volume":"252","author":"Haustein","year":"2002","journal-title":"J Int Med"},{"key":"10.1016\/j.jash.2012.11.003_bib25","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1524-6175.2005.04597.x","article-title":"Blood pressure circadian rhythm and endothelial function in heavy smokers: acute effects of transdermal nicotine","volume":"7","author":"Yugar-Toledo","year":"2005","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.jash.2012.11.003_bib26","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1161\/01.HYP.0000219284.47970.34","article-title":"Acute cardiovascular and sympathetic effects of nicotine replacement therapy","volume":"47","author":"Najem","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2012.11.003_bib27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/08037050903289606","volume":"18","author":"Martins","year":"2009","journal-title":"Blood Press"},{"key":"10.1016\/j.jash.2012.11.003_bib28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-2999(00)00194-1","article-title":"Endothelin ET(A) receptor antagonism attenuates the pressor effects of nicotine in rats","volume":"396","author":"Tanus-Santos","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jash.2012.11.003_bib29","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0735-1097(01)01124-X","article-title":"Risk of acute first myocardial infarction and use of nicotine patches in the general population","volume":"37","author":"Kimmel","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jash.2012.11.003_bib30","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/00002018-199818040-00005","article-title":"A meta-analysis to assess the incidence of adverse effects associated with the transdermal nicotine patch","volume":"18","author":"Greenland","year":"1998","journal-title":"Drug Safety"},{"key":"10.1016\/j.jash.2012.11.003_bib31","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.amjcard.2004.12.039","article-title":"Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes","volume":"95","author":"Meine","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jash.2012.11.003_bib32","article-title":"Effect of nicotine replacement therapy on cardiovascular outcomes after acute coronary syndromes","author":"Woold","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jash.2012.11.003_bib33","unstructured":"Zyban Package Insert. Available at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/020711s036lbl.pdf. Accessed August 15,\u00a02012."},{"key":"10.1016\/j.jash.2012.11.003_bib34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/09595230100100642","article-title":"Review of bupropion for smoking cessation","volume":"22","author":"Richmond","year":"2003","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.jash.2012.11.003_bib35","first-page":"247","article-title":"Cardiovascular effects of imipramine and bupropion in depressed patients with congestive heart failure","volume":"7","author":"Roose","year":"1987","journal-title":"J Clin Psychcopharmacol"},{"key":"10.1016\/j.jash.2012.11.003_bib36","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1176\/ajp.148.4.512","article-title":"Cardiovascular effects of bupropion in depressed patients with heart disease","volume":"148","author":"Roose","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jash.2012.11.003_bib37","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0149-2918(00)88301-0","article-title":"Safety profile of sustained-release bupropion in depression: results of three clinical trials","volume":"21","author":"Settle","year":"1999","journal-title":"Clin Ther"},{"key":"10.1016\/j.jash.2012.11.003_bib38","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.amjmed.2006.04.024","article-title":"Bupropion for smokers hospitalized with acute cardiovascular disease","volume":"119","author":"Rigotti","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.jash.2012.11.003_bib39","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0195-668X(03)00003-4","article-title":"Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicenter randomized study","volume":"24","author":"Tonstad","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jash.2012.11.003_bib40","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1001\/archinternmed.2011.72","article-title":"Bupropion for smoking cessation in patients with acute coronary syndrome","volume":"171","author":"Planer","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jash.2012.11.003_bib41","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/JCP.0b013e318172424e","article-title":"A randomized, double-blind, placebo-controlled study of the effects of sustained-release bupropion on blood pressure in individuals with mild untreated hypertension","volume":"28","author":"Thase","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jash.2012.11.003_bib42","unstructured":"Chantix. Package Insert. Available at http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/021928s028lbl.pdf. Accessed August 6,\u00a02012."},{"key":"10.1016\/j.jash.2012.11.003_bib43","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.neuropharm.2006.10.016","article-title":"Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid","volume":"52","author":"Rollema","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jash.2012.11.003_bib44","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/mol.106.025130","article-title":"Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors","volume":"70","author":"Mihalak","year":"2006","journal-title":"Molecular Pharmacol"},{"key":"10.1016\/j.jash.2012.11.003_bib45","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.autneu.2011.05.005","article-title":"The effect of varenicline on heart rate variability in healthy smokers and nonsmokers","volume":"164","author":"Ari","year":"2011","journal-title":"Autonom Neurosci Basic Clin"},{"key":"10.1016\/j.jash.2012.11.003_bib46","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1152\/jn.00934.2002","article-title":"Endogenous acetylcholine and nicotine activation enhances gabaergic and glycinergic inputs to cardiac vagal neurons","volume":"89","author":"Wang","year":"2003","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.jash.2012.11.003_bib47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.296.1.47","article-title":"Varenicline, an alpha4beta2 nicotine acetylcholine receptor partial agonist, vs sustained release bupropion and placebo for smoking cessation","volume":"296","author":"Gonzales","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2012.11.003_bib48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.296.1.56","article-title":"Efficacy of varenicline an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation","volume":"296","author":"Jorenby","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2012.11.003_bib49","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.296.1.64","article-title":"Effect of maintenance therapy with varenicline on smoking cessation","volume":"296","author":"Tonstand","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2012.11.003_bib50","unstructured":"Food and Drug Administration Safety Communication. Chantix (varenicline) may increase the risk of certain cardiovascular adverse events in patients with cardiovascular disease. Available at: http:\/\/www.fda.gov\/Drugs\/Drugsafety\/ucm259161.htm. (Accessed August 6, 2012)."},{"key":"10.1016\/j.jash.2012.11.003_bib51","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1503\/cmaj.110218","article-title":"Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis","volume":"183","author":"Singh","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/j.jash.2012.11.003_bib52","doi-asserted-by":"crossref","first-page":"e2856","DOI":"10.1136\/bmj.e2856","article-title":"Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis","volume":"344","author":"Prochaska","year":"2012","journal-title":"BMJ"}],"container-title":["Journal of the American Society of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171112002896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171112002896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T14:19:11Z","timestamp":1562509151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933171112002896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1933171112002896"],"URL":"https:\/\/doi.org\/10.1016\/j.jash.2012.11.003","relation":{},"ISSN":["1933-1711"],"issn-type":[{"value":"1933-1711","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}